Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas

被引:46
作者
Yan, P
Benhattar, J
Coindre, JM
Guillou, L
机构
[1] Univ Lausanne, Inst Pathol, CH-1011 Lausanne, Switzerland
[2] Univ Bordeaux 2, F-33076 Bordeaux, France
关键词
soft tissue neoplasms; sarcomas; telomerase; hTERT; telomere; telomere length; TRAP assay;
D O I
10.1002/ijc.10285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a previous study, we showed that telomerase activity (TA) and human telomerase reverse transcriptase (hTERT) mRNA expression were undetectable in benign mesenchymal lesions and low-grade soft tissue sarcomas (STSs), but detectable in about 50% of intermediate-/high-grade STSs. We wondered if this lack of TA or hTERT mRNA expression could be related to the tumor sample examined and if there was a relationship between the former 2 parameters and telomere length. Two separate tumor samples from 37 STSs were examined for telomerase activity, using the telomerase repeat amplification protocol (TRAP) assay and for hTERT mRNA expression, using RT-PCR. Telomere length was determined in each tumor sample, using the terminal restriction fragments (TRF) technique. Significant variations in telomere length, TA and hTERT mRNA expression between 2 samples of the same tumor were observed in 27%, 11% and 27% of STSs, respectively. Telomere length did not correlate with TA or hTERT mRNA expression. Despite great intra-tumoral heterogeneity in telomere length, short and long telomeres were more often seen in the low/intermediate-grade and high-grade STS categories, respectively. Few STSs that showed a TRF pattern suggestive of alternative lengthening of telomeres (ALT) may contain ALT subpopulations. (C) 2002 Wiley-Liss. Inc.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 53 条
[1]   SIGNIFICANT TELOMERE SHORTENING IN CHILDHOOD LEUKEMIA [J].
ADAMSON, DJA ;
KING, DJ ;
HAITES, NE .
CANCER GENETICS AND CYTOGENETICS, 1992, 61 (02) :204-206
[2]  
Aogi K, 2000, CLIN CANCER RES, V6, P4776
[3]   Telomere maintenance mechanisms as a target for drug development [J].
Bearss, DJ ;
Hurley, LH ;
Von Hoff, DD .
ONCOGENE, 2000, 19 (56) :6632-6641
[4]   TELOMERE ELONGATION IN IMMORTAL HUMAN-CELLS WITHOUT DETECTABLE TELOMERASE ACTIVITY [J].
BRYAN, TM ;
ENGLEZOU, A ;
GUPTA, J ;
BACCHETTI, S ;
REDDEL, RR .
EMBO JOURNAL, 1995, 14 (17) :4240-4248
[5]   Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines [J].
Bryan, TM ;
Englezou, A ;
DallaPozza, L ;
Dunham, MA ;
Reddel, RR .
NATURE MEDICINE, 1997, 3 (11) :1271-1274
[6]  
Carey LA, 1998, CLIN CANCER RES, V4, P435
[7]   Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization [J].
Counter, CM ;
Hahn, WC ;
Wei, WY ;
Caddle, SD ;
Beijersbergen, RL ;
Lansdorp, PM ;
Sedivy, JM ;
Weinberg, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14723-14728
[8]   Telomere maintenance by recombination in human cells [J].
Dunham, MA ;
Neumann, AA ;
Fasching, CL ;
Reddel, RR .
NATURE GENETICS, 2000, 26 (04) :447-450
[9]   Complex regulation of telomerase activity - Implications for cancer therapy [J].
Elenitoba-Johnson, KSJ .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (02) :405-410
[10]   Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma [J].
Guillou, L ;
Coindre, JM ;
Bonichon, F ;
Bui, NB ;
Terrier, P ;
Collin, F ;
Vilain, MO ;
Mandard, AM ;
LeDoussal, V ;
Leroux, A ;
Jacquemier, J ;
Duplay, H ;
SastreGarau, X ;
Costa, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :350-362